Prof. Dr. Mustafa Özdoğan
-
★2016International Guidelines Reference Research AwardTurkish Medical Oncology Association
-
2016Best Poster Presentation AwardTurkish Medical Oncology Congress
-
2016Best Poster Presentation AwardAegean Hematology-Oncology Congress
-
2015Poster Presentation AwardTurkish National Cancer Congress
-
2013Oral Presentation First PrizeTurkish Society of Interventional Radiology
-
2012Selected Oral Presentation AwardTurkish Medical Oncology Congress
What Prof. Dr. Mustafa Özdoğan does
Diagnosis and medical treatment of solid tumours — chemotherapy, immunotherapy and targeted-therapy programmes built around the patient's molecular profile.
-
01Breast cancer treatmentSystemic therapy across all stages, neoadjuvant and adjuvant programmes
-
02Head & neck cancersMultidisciplinary protocols with radiation oncology and surgical teams
-
03Gynaecological cancersOvarian, endometrial and cervical cancer chemotherapy
-
04Lung cancerTargeted therapy and immunotherapy for NSCLC and SCLC
-
05Colorectal & gastric cancersChemotherapy and biologic agents
-
06Immunotherapy programmesCheckpoint inhibitors across multiple solid tumours
-
07Hereditary cancer counsellingBRCA, Lynch and other syndromes
Timeline
Career milestones across academia and the Memorial Health Group.
Scientific work
Over 100 peer-reviewed articles. Google Scholar profile shows 5,000+ total citations and h-index 34. Selected oncology publications below.
-
2021Lancet Oncol«Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial»· co-author · 695 citations
-
2016J BUON«Curcumin (Turmeric) and cancer»· senior author · 159 citations
-
2004Support Care Cancer«'Do not tell': what factors affect relatives' attitudes to honest disclosure of diagnosis to cancer patients?»· first author · 128 citations
-
2004Cytokine«Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy»· co-author · 127 citations
-
2009Clin Exp Dermatol«Complete remission of psoriasis following bevacizumab therapy for colon cancer»· senior author · 109 citations
-
2006J Palliat Med«Factors related to truth-telling practice of physicians treating patients with cancer in Turkey»· first author · 89 citations
Where they practise
Direct contract with BergemHealth at every listed clinic.
Tell me about your case — I’ll read it personally.
Fill in the short form on the consultation page — diagnosis, preferred timing, attached records. We assemble a tumour board for your case and reply within 4 hours.
Open the consultation form- Reply within 4 hours during business hours
- Confidentiality guaranteed
- Coordinator-translator inside the doctor’s office
- Tumour board of 2–3 professors within 72 hours
Similar BergemHealth professors
Adjacent specialties and second opinions. Direct contracts, verified cases.